Payload Logo
Pharma

Protalix: Q3 Earnings Snapshot

By AP News
Published

HACKENSACK, N.J. (AP) — HACKENSACK, N.J. (AP) — Protalix BioTherapeutics Inc. (PLX) on Monday reported a loss of $1.9 million in its third quarter.

The Hackensack, New Jersey-based company said it had a loss of 4 cents per share.

The drug developer posted revenue of $10.3 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLX at https://www.zacks.com/ap/PLX

📬 Sign up for the Daily Brief

Our free, fast and fun briefing on the global economy, delivered every weekday morning.